top of page
Picture1.png

​

We are a computational omics lab at the University of Pittsburgh and affiliated with the Department of Biomedical Informatics, Bioengineering and UPMC Hillman Cancer Center. The primary focus of our group is developing integrative statistical and machine learning approaches for extracting therapeutic insight from highly heterogenous omic datasets, clinical and drug response data for the purpose of precision medicine. Our projects are in the areas of systems biology, epigenetics, and immunology and are executed through multi-disciplinary collaborations.

​

NEWS

 2023

  • Our paper in collaboration with Vignali and Oesterreich Lab, "Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment", is published in Nature Cancer

  • Sanghoon Lee receives Hillman Postdoctoral Fellowship for Innovative Cancer Research

​

2022

  • Our paper "Isolated BAP1 loss in malignant pleural mesothelioma predicts immunogenicity with implications for immunotherapeutic response" is published in Cancers

  • The lab receives an Maximizing Investigators' Research Award (MIRA) for Early-Stage Investigators (R35)

  • Maneka Puligandla receives Hillman Medical Student Fellowship for Innovative Cancer Research 

  • Our paper "Interpretable deep learning for chromatin-informed inference of transcriptional programs driven by somatic alterations across cancers" is published in Nucleic Acids Research

  • Our paper in collaboration with Bakkenist Lab, "Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression", is published in Cell Reports

  • April Sagan's abstract “STAN, a computational framework for inferring spatially informed transcription factor activity networks” selected for oral presentation at the 14th annual RECOMB/ISCB Conference on Regulatory & Systems Genomics

  • Our paper "Chromatin accessibility and active transcription factors in primary human invasive lobular and ductal breast carcinomas" is published in Breast Cancer Research

​

2021

  • Our paper in collaboration with Buckanovich Lab, "Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition", is published in Science Advances

  • Our paper "SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators" is published in Nucleic Acids Research

  • Our paper in collaboration with Cheng Lab, "Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis", is published in Cancer Cell

  • Our paper in collaboration with Duvvuri  Lab, "Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation", is published in Clinical Cancer Research

​

2019

  • The lab receives an Award from The Fund for Innovation in Cancer Informatics

  • Our paper in collaboration with Bakkenist Lab, "WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1 and S phase cells", is published in Proc Natl Acad Sci.

  • Our paper "Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers" is published in Nature Communications 

  • Our paper in collaboration with Bakkenist Lab, "An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication", is published in Proc Natl Acad Sci.

  • The lab receives an NCI R00 Award

bottom of page